What is the recommended treatment for duodenitis?

Treatment of Duodenitis

Test for H. pylori and treat with eradication therapy (PPI plus two antibiotics for 1 week) if positive, as this achieves >90% healing rates and symptom resolution in H. pylori-associated duodenitis.

Algorithmic Approach to Treatment

Step 1: Test for H. pylori Infection

• All patients with duodenitis should be tested for H. pylori using urea breath test or monoclonal stool antigen test 1
• H. pylori is present in 100% of erosive duodenitis cases in some studies 2
• Duodenitis should be considered a variant form of duodenal ulcer disease 2

Step 2: H. pylori-Positive Duodenitis Treatment

Eradication Regimen:

• PPI (omeprazole 20 mg twice daily) PLUS two antibiotics for 1 week 1, 2:
  • Clarithromycin 500 mg twice daily + Amoxicillin 1 g twice daily, OR
  • Clarithromycin 500 mg twice daily + Metronidazole 500 mg twice daily
• Select regimen based on local clarithromycin resistance patterns (use alternative if resistance >20%) 1

Post-Eradication Management:

• For uncomplicated duodenitis: NO prolonged PPI therapy needed after eradication 1
• For complicated duodenitis: Continue PPI until H. pylori eradication confirmed 1
• Confirm eradication at least 4 weeks after completing treatment using urea breath test 1

Expected Outcomes:

• Erosion healing achieved in 86% of successfully eradicated patients vs. only 37% in treatment failures 2
• Eradication is the only variable correlating with erosion healing (odds ratio 10) 2
• Symptomatic improvement and histological gastritis resolution occur with successful eradication 2

Step 3: H. pylori-Negative or Functional Duodenitis

For duodenitis without H. pylori or functional dyspepsia with duodenal inflammation:

First-Line:

• PPI therapy (e.g., omeprazole 20-40 mg daily) for 4-8 weeks 3, 4
• PPIs have anti-inflammatory effects independent of acid suppression 3

Alternative Options:

• H2-receptor antagonists (nizatidine 150 mg twice daily shows moderate efficacy) 5
• Consider anti-inflammatory approaches targeting duodenal eosinophil-mast cell axis 3

Step 4: Refractory or Special Cases

If symptoms persist despite eradication:

• Repeat endoscopy at 6 months
• Reconfirm H. pylori status
• Consider second-line eradication therapy if reinfection occurred 1

IBD-Associated Duodenitis:

• Requires treatment of underlying IBD with appropriate immunosuppression
• Case reports show success with advanced therapies like upadacitinib in steroid-dependent cases 6

Critical Pitfalls to Avoid

• Do not skip H. pylori testing - assuming duodenitis is functional without testing misses the most treatable cause
• Do not use serology for H. pylori diagnosis or follow-up - only urea breath test or monoclonal stool antigen are validated 1
• Do not test for eradication success before 4 weeks - earlier testing yields false results 1
• Do not continue long-term PPI in uncomplicated cases after successful eradication - this is unnecessary and increases costs/side effects 1
• Do not delay eradication therapy - in bleeding cases, start treatment when oral feeding resumes 1

Evidence Quality Note

The Maastricht IV/Florence Consensus guidelines 1 provide Level 1a-1b evidence with Grade A recommendations for H. pylori management in peptic disease, which duodenitis represents a variant of. The prospective study by 2 demonstrates 100% H. pylori prevalence in erosive duodenitis with 86% overall eradication success, strongly supporting this as first-line therapy.